These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8254619)

  • 21. Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.
    Misra RN; Brown BR; Sher PM; Patel MM; Hall SE; Han WC; Barrish JC; Kocy O; Harris DN; Goldenberg HJ
    J Med Chem; 1993 May; 36(10):1401-17. PubMed ID: 8496908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of anti-aggregatory effects of PGI2, PGI3 and iloprost on human and rabbit platelets.
    Kobzar G; Mardla V; Järving I; Samel N
    Cell Physiol Biochem; 2001; 11(5):279-84. PubMed ID: 11684817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.
    Alvarez R; Eglen RM; Chang LF; Bruno JJ; Artis DR; Kluge AF; Whiting RL
    Prostaglandins; 1991 Aug; 42(2):105-19. PubMed ID: 1775633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and pharmacological activity of arene-fused prostacyclin analogues on human platelets.
    Jakubowski JA; Utterback BG; Mais DE; Hardinger SA; Braish TF; Nevill CR; Fuchs PL
    Prostaglandins; 1994 Mar; 47(3):189-201. PubMed ID: 8016389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
    Hermán F; Hadházy P; Magyar K
    Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New pyrazolylhydrazone derivatives as inhibitors of platelet aggregation.
    da Silveira IA; Paulo LG; de Miranda AL; Rocha SO; Freitas AC; Barreiro EJ
    J Pharm Pharmacol; 1993 Jul; 45(7):646-9. PubMed ID: 8105062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
    Yang J; Hua WY; Wang FX; Wang ZY; Wang X
    Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AH6809, a prostaglandin DP-receptor blocking drug on human platelets.
    Keery RJ; Lumley P
    Br J Pharmacol; 1988 Jul; 94(3):745-54. PubMed ID: 2460179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationship between prostacyclin and its platelet receptor. Correlation of structure change and the platelet activity.
    Tsai AL; Wu KK
    Eicosanoids; 1989; 2(3):131-43. PubMed ID: 2517029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids.
    de Candia M; Summo L; Carrieri A; Altomare C; Nardecchia A; Cellamare S; Carotti A
    Bioorg Med Chem; 2003 Apr; 11(7):1439-50. PubMed ID: 12628670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG; Wong T; Frojmovic MM
    Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostacyclin (PGI) receptor binding and cyclic AMP synthesis activities of PGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells.
    Oka M; Negishi M; Yamamoto T; Satoh K; Hirohashi T; Ichikawa A
    Biol Pharm Bull; 1994 Jan; 17(1):74-7. PubMed ID: 7511960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute reversible reduction of PGI2 platelet receptors after iloprost infusion in man.
    Modesti PA; Fortini A; Poggesi L; Boddi M; Abbate R; Gensini GF
    Thromb Res; 1987 Dec; 48(6):663-9. PubMed ID: 2448896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.